Send a text

  Bugs, drugs, and optimal duration for antibiotic therapy? New frontiers in HIV treatment? Listen this week as Kieran and Jay Spiegel, a resident in General Internal Medicine in Toronto, discuss two studies: It’s hard to remember what the right drug is to treat a certain bug, let alone the correct duration of therapy. Further, ...

The post Bugs & Drugs – Duration of Antibiotic Therapy in Community-Acquired Pneumonia and Early Antiretroviral Treatment for HIV appeared first on Healthy Debate.

Send a text

This week Kieran and Dr. Fraser Pollard, a Family Physician in Trenton, Ontario, discuss two studies: Using long acting beta agonists (LABAs) safely and appropriately in the management of asthma is widely debated, with evidence suggesting a potential risk of serious asthma-related events associated with the use of LABAs. But is the potential risk warranted? ...

The post Dazed and Confused – Dexmedetomidine for the Prevention of Delirium and the Safety of LABAs in Asthma appeared first on Healthy Debate.

Send a text

We’re back and better than ever with a NEW host! This season, Kieran Quinn takes the reigns and is excited to bring you the latest and greatest in the world of emerging clinical evidence. Along outgoing host Amol Verma, the two hosts discuss two studies: Just how dangerous are opioids in the treatment of chronic pain ...

The post Drugs on the Brain: Opining on Opioid-Induced Death and Ticagrelor for TIA or Stroke appeared first on Healthy Debate.

Send a text

This week, Amol and Dr. Kieran Quinn, both general internal medicine residents at the University of Toronto, discuss two studies: Where do people die? What types of care do they utilize at the end of life? A retrospective cohort study of people who died with cancer in seven developed countries evaluated the number of deaths ...

The post Summer Replay – Valued Care: End of Life Care and Early Trends from “Choosing Wisely” appeared first on Healthy Debate.

Send a text

This week, Amol, resident in General Internal Medicine at University of Toronto, and Mike Fralick, chief medical resident at St. Michael’s Hospital in Toronto, talk about 2 blood pressure studies: A meta-analysis and systematic review found that more intensive blood pressure lowering was associated with improved cardiovascular outcomes and albuminuria. Amol discusses the trade-offs of ...

The post Summer Replay – The SPRINT to lower blood pressure appeared first on Healthy Debate.

Send a text

This week Amol and Nathan discuss two studies: A multi-centre, prospective study evaluated the physical and mental health status of caregivers for patients discharged from the intensive care unit (ICU). Using hospital data and self-administered questionnaires, the study found most caregivers of critically ill patients are at high risk for depression, anxiety and poor mental health. ...

The post Summer Replay – Caregivers in the ICU and Symptoms in Smokers appeared first on Healthy Debate.

Send a text

This week, Amol and Kieran discuss two studies: How can we prevent readmission? An observational study of 1000 general internal medicine patients from 12 United States academic medical centres found that 26.9% of readmissions were potentially preventable. Key factors associated with potential preventability included decision making in the emergency department, lack of information to outpatient ...

The post Summer Replay – Pondering Preventability: Readmissions and Catheter-Associated UTI appeared first on Healthy Debate.

Send a text

This week, Amol talks about new antithrombotic therapy guidelines and using low calorie diet for diabetes remission. The American College of Chest Physicians issued new antithrombotic guidelines for the treatment of venous thromboembolism in February 2016. Amol highlights five updates in the guidelines, and discusses the evidence behind each recommendation. Diabetes has long been described ...

The post Summer Replay: New Antithrombotic Therapy Guidelines and Low Calorie Diet for Diabetes Remission appeared first on Healthy Debate.

Send a text

This is our final episode of the year! We want to thank everyone who has hosted or contributed to the podcast, and of course you – our dear listeners – for tuning in every week. We will be re-playing some of our favourite past episodes, and bringing you brand new content in the fall. Good ...

The post Season Finale: All ‘Good Stuff’ Must Come to an End appeared first on Healthy Debate.

Send a text

This week, Amol and Rebecca discuss a recent study and an updated recommendation: A multi-centre, randomized control trial (the LEADER trial) examined the cardiovascular effect of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue. Patients with type 2 diabetes and high cardiovascular risk were randomly assigned to receive either standard of care plus liraglutide or standard of ...

The post Motherhood Statements: Cardiovascular Effect of Liraglutide and Syphilis Screening appeared first on Healthy Debate.